Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Titan Biotech Ltd
Your Vote -
Buy
52.00%
Hold
20.00%
Sell
28.00%
52.00%
25 users have voted
Option Chain
Analyzes market sentiment, predicts Titan Biotech Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Titan Biotech - Newspaper Advertisement Pertaining To Transfer Of Physical Shares Under Special Window
-
Titan Biotech Ltd. has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025
-
Titan Biotech Ltd. - Re-Lodgement Of Transfer Requests Of Physical Shares
-
Titan Biotech Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Titan Biotech Ltd. - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 20
-
Titan Biotech Ltd. - Intimation Of Record Date For Sub Division / Split Of Equity Shares Of The Company
-
Titan Biotech Ltd. - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Titan Biotech Ltd. - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
-
Titan Biotech Ltd. - Disclosure Under Regulation 7 Of SEBI (Prevention Of Insider Trading ) Regulations
-
Titan Biotech Ltd. - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Titan Biotech Ltd. - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
-
Titan Biotech Ltd. - Corporate Action-Intimation of Sub division / Stock Split
-
Titan Biotech Ltd. - Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th November, 2025\r\n
-
Titan Biotech Ltd. - Board Meeting Intimation for Proposal For Alteration In The Share Capital Of The Company By Sub-Division
-
Titan Biotech Q2 net profit up 37.20% at Rs 6.86 cr
-
Titan Biotech Ltd. - Consolidated And Standalone Unaudited Financial Results For The Quarter And Half Year Ended September 30
-
Titan Biotech Ltd. - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30,
-
Titan Biotech Ltd. - Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results
Key fundamentals
Evaluate the intrinsic value of Titan Biotech Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 147.2358 | 135.613 | 113.0902 | 92.0429 | 73.3559 |
| Liabilities | 147.2358 | 135.613 | 113.0902 | 92.0429 | 73.3559 |
| Equity | 8.2637 | 8.2637 | 8.2637 | 8.2637 | 8.2637 |
| Gross Profit | 25.4264 | 34.2814 | 29.5192 | 31.1807 | 41.8054 |
| Net Profit | 18.2711 | 23.6632 | 21.0248 | 21.6843 | 28.7726 |
| Cash From Operating Activities | 20.1233 | 21.1463 | 21.1783 | 21.9524 | 17.7452 |
| NPM(%) | 11.67 | 14.42 | 14.6 | 17.55 | 23.49 |
| Revenue | 156.4508 | 164.0721 | 143.9993 | 123.5488 | 122.4593 |
| Expenses | 131.0244 | 129.7907 | 114.4801 | 92.3681 | 80.6538 |
| ROE(%) | 10.97 | 14.21 | 12.63 | 13.03 | 17.28 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Titan Biotech Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 164.45 | 0.37 | 44.14 | 5876.10 | 164.61 | 0.00 |
| Jain Irrigation Systems Ltd | 35.80 | -1.32 | 43.77 | 67684.84 | 23.46 | 0.00 |
| Tierra Agrotech Ltd | 47.28 | -0.04 | 0.00 | 6423.92 | -17.66 | 0.00 |
| Kohinoor Foods Ltd | 23.80 | 1.15 | 0.24 | 3630.60 | 983.92 | 0.00 |
Company Info
Titan Medicares Ltd. (hereinafter referred to as "The Company" or TML) was incorporated as a public limited company on 18th February, 1992 under the Companies Act, 1956 and obtained the certificate of Commencement of Business on 25th February, 1992 from the Registrar of Companies Delhi & Haryana at New Delhi. 2007 - The Company has recently bagged export orders more than USD 130000 for export of its products. 2010 - Titan Biotech Ltd has recommended dividend of 5% on equity shares i.e. Rs. 0.50 per share. 2014 - Titan Biotech Ltd has recommended dividend of Rs. 0.75 per equity share of Rs. 10/- each.
Titan Medicares Ltd. (hereinafter referred to as "The Company" or TML) was incorporated as a public limited company on 18th February, 1992 under the Companies Act, 1956 and obtained the certificate of Commencement of Business on 25th February, 1992 from the Registrar of Companies Delhi & Haryana at New Delhi. 2007 - The Company has recently bagged export orders more than USD 130000 for export of its products. 2010 - Titan Biotech Ltd has recommended dividend of 5% on equity shares i.e. Rs. 0.50 per share. 2014 - Titan Biotech Ltd has recommended dividend of Rs. 0.75 per equity share of Rs. 10/- each.
Read More
Parent Organisation
Titan Biotech Ltd.
Founded
18/02/1992
Managing Director
Mr.Naresh Kumar Singla
NSE Symbol
FAQ
The current price of Titan Biotech Ltd is
The 52-week high for Titan Biotech Ltd is
The market capitalization of Titan Biotech Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Titan Biotech Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Titan Biotech Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Titan Biotech Ltd shares.
The CEO of Titan Biotech Ltd is Mr.Naresh Kumar Singla, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
